Log In | Shopping Cart | Advanced Search
            
  • Home
  • Career
  • Distributors
  • Contact Us:
  • Email: crm@excellgen.com
Products
Modified mRNA
Encapsulated mRNA
mRNA Enzyme
SARS-CoV-2
Pseudovirus
Popular Products
Cancer Proteins
Antibodies
DNA Binding Proteins
Electrophoresis
Genome Engineering
Polymerases
Recombinases
Transcription Factors
Transfection
Services
Modified mRNA
Custom Cloning
Virus Production
Protein Purification
Protein Expression
Modified mRNA
 Previous 
 Return to List 
 Next 

SARS-CoV-2 Spike Glycoprotein Delta Variant (B.1.617.2, Indian origin) mRNA

Catalog #: EG-346


Please Choose:



Qty:

Product Name SARS-CoV-2 Spike Glycoprotein Delta Variant (B.1.617.2, Indian origin) mRNA
Description

This modified mRNA encodes the full-length SARS-CoV-2 spike glycoprotein B.1.617.2 India origin delta variant.

Features
  • 5' Cap: Capped with ARCA (Anti Reverse Cap Analog, m7(3'-O-methyl)-G(5')ppp(5')G, Cap 0) or CleanCap AG (m7G(5')ppp(5')(2'OMeA)pG, Cap 1)
  • 5’-UTR: derived from human alpha-globin RNA with an optimized Kozak sequence
  • Codon Optimization: Human
  • Mutations: T19R, T95I, G142D, ∆F157+∆R158, E156G, L452R, T478K, D614G, P681R, D950N
  • Nucleotide Modifications: mRNA modified with both Pseudo-UTP and 5mCTP
  • 3’-UTR: comprises two sequence elements derived from the amino-terminal enhancer of split (AES) mRNA and the mitochondrial encoded 12S ribosomal RNA to confer RNA stability and high total protein expression.
  • PolyA: 180 nt
Sequence Available upon request.
Application Animal Vaccine Research (Not for human use)
Concentration ~1 μg/μl
Transfection Protocol Lipofectamine™ MessengerMAX™ Transfection Reagent Protocol
QC Agarose gel electrophoresis
Shipping Dry ice
Storage -80 oC

     
 Ask a Question 
 
 Home | Privacy Policy | Terms & Conditions | Online Price Policy | Shipping & Return

Copyright © 2007-2022  Excellgen, Inc. All rights reserved